Literature DB >> 8209269

Nasopharyngeal carcinoma: the Epstein-Barr virus association.

D Liebowitz1.   

Abstract

The etiology of NPC is multifactorial and includes virological, genetic, and environmental factors as described. These factors can be synthesized into a model for the development of NPC through a multistep process. First, an individual may carry a genetic predisposed risk of developing NPC as suggested by the HLA linkage of the disease. The nasopharyngeal epithelium becomes infected early in life by EBV and viral gene expression eventually becomes limited to EBNA-1, LMP1, LMP2A/2B, and perhaps another viral protein not yet fully characterized. LMP1 has profound growth stimulating effects in vitro and may exert similar effects in the nasopharyngeal epithelium. As cells are stimulated to divide, the presence of EBNA-1 ensures that the viral genome will replicate and be distributed to progeny cells. Finally, to reach their full malignant potential, the dividing nasopharyngeal cells may acquire cellular genetic changes involving recessive TSGs on chromosome 3. The risk for developing secondary genetic alterations involving these genes may be increased by exposure to environmental carcinogens such as volatile nitrosamines in salted fish. Thus, NPC provides a model system for understanding the interactions of genetic, infectious, and environmental factors involved in oncogenic transformation. Recent developments in organoculture systems and transgenic animal technology should allow dissection at the molecular level of the specific mechanisms involved in this process.

Entities:  

Mesh:

Year:  1994        PMID: 8209269

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  38 in total

1.  Morphometric study of tumor angiogenesis as a new prognostic factor in nasopharyngeal carcinoma patients.

Authors:  L Rubio; J S Burgos; C Morera; F J Vera-Sempere
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal.

Authors:  Breda Eduardo; Catarino Raquel; Medeiros Rui
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-08       Impact factor: 2.503

3.  Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents.

Authors:  Sajal K Ghosh; Susan P Perrine; Robert M Williams; Douglas V Faller
Journal:  Blood       Date:  2011-12-07       Impact factor: 22.113

Review 4.  Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis.

Authors:  Javier S Burgos
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

5.  The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area.

Authors:  Ying-En Lee; Hong-Lin He; Tzu-Ju Chen; Sung-Wei Lee; I-Wei Chang; Chung-Hsi Hsing; Chien-Feng Li
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

6.  Epstein-Barr virus latent membrane protein 1 is not associated with vessel density nor with hypoxia inducible factor 1 alpha expression in nasopharyngeal carcinoma tissue.

Authors:  Alexander A Benders; Weihua Tang; Jaap M Middeldorp; Astrid E Greijer; Leigh B Thorne; William K Funkhouser; W Kimryn Rathmell; Margaret L Gulley
Journal:  Head Neck Pathol       Date:  2009-11-12

7.  Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis.

Authors:  Rasheed Ahmad; Sardar T A Sindhu; Emil Toma; Richard Morisset; Ali Ahmad
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene.

Authors:  V E Nava; E H Cheng; M Veliuona; S Zou; R J Clem; M L Mayer; J M Hardwick
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.

Authors:  Wen-hai Feng; Eva Westphal; Amy Mauser; Nancy Raab-Traub; Margaret L Gulley; Pierre Busson; Shannon C Kenney
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  Biomolecular markers in cancer of the tongue.

Authors:  Daris Ferrari; Carla Codecà; Jessica Fiore; Laura Moneghini; Silvano Bosari; Paolo Foa
Journal:  J Oncol       Date:  2009-08-19       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.